Built on MVE’s legacy SC 4/2V and 4/3V vapor shipper platform, the next-generation SC 4/2V and 4/3V models have been ...

Celltrion USA announced that Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo), biosimilars referencing Prolia ...

Dr. Richard Philipson has been appointed Chief Medical Officer (CMO) of Hansa Biopharma AB, effective July 14.

Centauri Therapeutics Limited, an immunotherapy company, has appointed Dr. Debra Barker as Chief Medical Officer (CMO).

Ibtrozi is a highly selective, next-generation oral ROS1 tyrosine kinase inhibitor (TKI) designed to address some of the outstanding challenges of treating ROS1+ NSCLC. The FDA approval of Ibtrozi is ...

Cellular Origins has successfully shown that its platform is able to fully automate cell therapy manufacturing processes using validated, off-the-shelf third-party instruments in combination with ...

AstraZeneca has entered a strategic research collaboration with China’s CSPC Pharmaceuticals Group Limited, focusing on the discovery and development of novel oral drug candidates for various chronic ...